IFG Advisory’s VanEck Pharmaceutical ETF PPH Stock Holding History

IFG Advisory’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$195K	Buy	1,782 +31	+2%	+$3.46K	0.01%	880
2026 Q2	$191K	Buy	+1,751	New	+$181K	0.01%	883
2023 Q1	–	Sell	-4,199	Closed	-$326K	–	522
2022 Q4	$326K	Buy	+4,199	New	+$310K	0.03%	382

Other funds holding PPH

J. Safra Asset Management New York $2.3B AUM 21.55% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Adamsbrown Wealth Consultants Wichita, Kansas $548M AUM 16.52% 1-Year Est. Return

Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return

Rye Brook Capital Greenwich, Connecticut $154M AUM 17.54% 1-Year Est. Return

WT Wealth Management Scottsdale, Arizona $357M AUM 15.82% 1-Year Est. Return

Prime Capital Investment Advisors Overland Park, Kansas $10.2B AUM 17.74% 1-Year Est. Return

Fortis Group Advisors Westwood, New Jersey $623M AUM 25.42% 1-Year Est. Return

Fluent Financial Dallas, Texas $292M AUM 8.92% 1-Year Est. Return

IFG Advisory's PPH Position: Q3 2026 in Review

IFG Advisory increased its VanEck Pharmaceutical ETF (PPH) stake by 1.8% in Q3 2026, buying an estimated $3.46K and bringing the position to 1,782 shares worth $195K. The position accounts for 0.01% of the portfolio, ranked #880.

IFG Advisory first reported a position in PPH in Q4 2022 and has held it in 3 quarters since. The position peaked at $326K in Q4 2022. 80 funds tracked by Wall St. Rank hold PPH as of Q3 2026.

IFG Advisory held 1,782 shares of VanEck Pharmaceutical ETF worth $195K as of Q3 2026.
IFG Advisory bought 31 VanEck Pharmaceutical ETF shares in Q3 2026, an estimated $3.46K.
VanEck Pharmaceutical ETF made up 0.01% of IFG Advisory's portfolio in Q3 2026, its #880 holding.
IFG Advisory first reported a position in VanEck Pharmaceutical ETF in Q4 2022 and has held it in 3 quarters since.
IFG Advisory's VanEck Pharmaceutical ETF position peaked at $326K in Q4 2022.
80 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2026.

Based on IFG Advisory's 13F filing for Q3 2026, filed 9 Nov 2026.